Extracellular vesicles deliver sodium iodide symporter protein and promote cancer cell radioiodine therapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Extracellular vesicles deliver sodium iodide symporter protein and promote cancer cell radioiodine therapy ; volume:12 ; number:1 ; day:1 ; month:7 ; year:2022 ; pages:1-8 ; date:12.2022
Scientific reports ; 12, Heft 1 (1.7.2022), 1-8, 12.2022
- Urheber
-
Lee, Jin Hee
Jung, Kyung-Ho
Mina, Kim
Lee, Kyung-Han
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-15524-9
- URN
-
urn:nbn:de:101:1-2022082122295276669176
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lee, Jin Hee
- Jung, Kyung-Ho
- Mina, Kim
- Lee, Kyung-Han
- SpringerLink (Online service)
Ähnliche Objekte (12)
Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodine
Transcriptional properties of the human sodium iodide symporter and thyroglobulin genes
Using TGF-β1 biology in radioiodine refractory differentiated thyroid cancer to re-establish sodium iodide symporter (NIS) expression using engineered mesenchymal stem cells as therapy vehicles
Subcellular distribution of the sodium iodide symporter in benign and malignant thyroid tissues
Targeted delivery of the theranostic sodium iodide symporter (NIS) for cancer gene therapy
High molar activity [18F]tetrafluoroborate synthesis for sodium iodide symporter imaging by PET
HMGB1-mediated autophagy regulates sodium/iodide symporter protein degradation in thyroid cancer cells
Targeted delivery of the theranostic sodium iodide symporter (NIS) for cancer gene therapy
Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer
Mesenchymal stem cell therapy using theranostic sodium iodide symporter effector gene in glioblastoma
Synergistic inhibition of MEK/ERK and BRAF V600E with PD98059 and PLX4032 induces sodium/iodide symporter (NIS) expression and radioiodine uptake in BRAF mutated papillary thyroid cancer cells
PI3K activation is associated with intracellular sodium/iodide symporter protein expression in breast cancer
Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodine
Transcriptional properties of the human sodium iodide symporter and thyroglobulin genes
Using TGF-β1 biology in radioiodine refractory differentiated thyroid cancer to re-establish sodium iodide symporter (NIS) expression using engineered mesenchymal stem cells as therapy vehicles
Subcellular distribution of the sodium iodide symporter in benign and malignant thyroid tissues
Targeted delivery of the theranostic sodium iodide symporter (NIS) for cancer gene therapy
High molar activity [18F]tetrafluoroborate synthesis for sodium iodide symporter imaging by PET
HMGB1-mediated autophagy regulates sodium/iodide symporter protein degradation in thyroid cancer cells
Targeted delivery of the theranostic sodium iodide symporter (NIS) for cancer gene therapy
Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer
Mesenchymal stem cell therapy using theranostic sodium iodide symporter effector gene in glioblastoma
Synergistic inhibition of MEK/ERK and BRAF V600E with PD98059 and PLX4032 induces sodium/iodide symporter (NIS) expression and radioiodine uptake in BRAF mutated papillary thyroid cancer cells
PI3K activation is associated with intracellular sodium/iodide symporter protein expression in breast cancer
Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodine
Transcriptional properties of the human sodium iodide symporter and thyroglobulin genes
Using TGF-β1 biology in radioiodine refractory differentiated thyroid cancer to re-establish sodium iodide symporter (NIS) expression using engineered mesenchymal stem cells as therapy vehicles
Subcellular distribution of the sodium iodide symporter in benign and malignant thyroid tissues
Targeted delivery of the theranostic sodium iodide symporter (NIS) for cancer gene therapy
High molar activity [18F]tetrafluoroborate synthesis for sodium iodide symporter imaging by PET
HMGB1-mediated autophagy regulates sodium/iodide symporter protein degradation in thyroid cancer cells
Targeted delivery of the theranostic sodium iodide symporter (NIS) for cancer gene therapy
Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer
Mesenchymal stem cell therapy using theranostic sodium iodide symporter effector gene in glioblastoma
Synergistic inhibition of MEK/ERK and BRAF V600E with PD98059 and PLX4032 induces sodium/iodide symporter (NIS) expression and radioiodine uptake in BRAF mutated papillary thyroid cancer cells